Physician profile
Michael Light
NPI 1255369534
$1,766.07
in general payments reported to CMS, 2019-2025
15 companies · $48.15 in 2025
The $48.15 reported for 2025 was less than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $501 · 2020: $77.59 · 2021: $144 · 2022: $275 · 2023: $574 · 2024: $147 · 2025: $48.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.69 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $313.94 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $268.19 | 2019-2023 | Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $186.36 | 2019-2023 | Nucala |
| Genzyme Corporation | $150.60 | 2022-2023 | |
| Amgen INC. | $123.35 | 2023 | Tezspire |
| Airehealth | $100.00 | 2019 | |
| Covis Pharma Gmbh | $96.38 | 2022 | |
| Gilead Sciences, INC. | $95.46 | 2019 | |
| Advanced Respiratory, INC | $91.65 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $84.99 | 2024 | |
| Baxter Healthcare | $62.78 | 2023-2024 | Hillrom - Volara System, Hillrom - Vest System Model 105 Home Care |
| Regeneron Healthcare Solutions, INC. | $60.95 | 2021 | |
| Janssen Pharmaceuticals, INC | $48.15 | 2025 | Invega Sustenna |
| Jazz Pharmaceuticals INC. | $42.90 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.37 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Light listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.